PMC73 EVALUATION OF GLP-1 PRODUCT ATTRIBUTES IN TREATING PEOPLE WITH TYPE-2 DIABETES IN US: COMPARING TIME-TRADEOFF AND WILLINGNESS-TO-PAY METHODOLOGIES  by Zanutto, E et al.
Abstracts A33
into the process as appropriate. RESULTS: Two main linguistic and conceptual issues 
emerged during the translation process. Firstly, when an original item used more than
one adjective to cover a single concept, some languages only had one term to express 
this. Secondly, there was the challenge of using culturally appropriate expressions for
taboo concepts such as suicide and self-harm, to ensure homogenous response across
all languages. CONCLUSIONS: The language versions of the GAD-7 and PHQ-9 were 
established according to a rigorous standardized methodology to facilitate interna-
tional comparison and pooling of data. The linguistic validation process aims to ensure
conceptual equivalence across different language versions on the basis of a pre-deﬁ ned 
concept list explaining what the original instrument should measure. The process as 
a whole supports the advantage of integrating international feedback on concepts and 
wording during the development of questionnaires.
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OBJECTIVES: To assess patient utilities for cost utility analyses in health economics 
two different ways of revealing preferences have been compared. Time trade-off (TTO) 
and willingness-to-pay (WTP) surveys have been completed comparing patients’ pref-
erence in product propositions. TTO yields estimates of the amount of time that
patients would be willing forego to achieve preferred products attributes, and WTP 
yields estimates of the amount of money that patients are willing to pay for products 
attributes. Despite their widespread use, results of the two methodologies have not, 
to our knowledge, been compared directly in diabetes. METHODS: The two methods
were used to evaluate the reactions of people with type-2 diabetes to two GLP-1
injectable diabetes medications that varied on four attributes: efﬁ cacy in controlling 
blood glucose (measured by HbA1c), dosing frequency (twice-daily vs. once-daily), 
incidence of hypoglycemia, and incidence of nausea. To maximize statistical power
and allow comparisons across patient groups, a large internet-based survey (more than 
500 respondents) was conducted in U.S. with four categories of self-identiﬁ ed patients 
who were sampled based on their medication history, and randomly assigned to either 
the TTO or WTP. RESULTS: Results suggest that the WTP methodology yields greater 
face validity and sensitivity than TTO (100% of respondents prefer the superior proﬁ le 
in WTP vs. 96% in TTO). Data from conjoint analysis designed to establish the 
importance of each of the four product attributes in the decision-making process used 
by patients reveal similar patterns of results for the two methodologies. CONCLU-
SIONS: Regardless of whether patients were in the group assigned to TTO or WTP,
patients perceive efﬁ cacy (HbA1c control) to be the most important product attribute,
followed by incidence of nausea. Patients evaluated the incidence of hypoglycemia and 
dosing schedule as less important relative to the HbA1c control and nausea in the 
decision-making process.
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OBJECTIVES: To evaluate the potential long-term health impact of helmet law, we 
calculated the loss of quality-adjusted life year (QALY) under different proportions of 
helmet wearing among the motorcyclists. METHODS: The quality-adjusted life expec-
tancies for helmeted and non-helmeted motorcyclists were estimated by adjusting the 
survival function based upon the Head Injury Registry with quality of life measures 
assessed under the EQ-5D questionnaire. We took Hualien County, where a lower rate 
of helmet wearing (77%) was reported, as an example to calculate the expected
numbers of prevented head-injured cases by multiplying the population at risk with 
the incidence rate of head injury for helmeted and non-helmeted motorcyclists. As dif-
ferent proportions of helmet-wearing and different proportions of full face helmet in 
motorcyclists were assumed, the expected numbers of prevented cases were calculated, 
which were multiplied with the loss of QALE of an average case to predict the potential 
beneﬁ t of helmet use. RESULTS: Under the current proportion of helmet wearing, the
annual loss associated with head injured was 4346.9 QALYs in Hualien County. If the
proportion of helmet wearing could be increased to 100%, the health beneﬁ t saved 
was estimated 1434.3 QALYs. If 80% of them used full face helmet, the total gain was 
increased to 2500 QALYs. CONCLUSIONS: The health beneﬁ t of helmet protection 
for head injury can be determined under units of quality-adjusted life year (QALY) and 
directly applied in future cost-effective analyses for public health policy.
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OBJECTIVES: To identify the types of and reasons for unusable preference survey
responses with the goal of informing improvements in health utility assessment meth-
odology. METHODS: We deﬁ ne typologies that represent unusable responses from
health utility surveys; present evidence from the literature on the frequency of such
responses; present empiric data on the rationale for such types of responses; and 
discuss methods for handing data that contain such responses, and implications for 
interpreting analytic results based on health utility data. RESULTS: Potentially unus-
able health utility survey responses include (1) illogical, (2) inconsistent, (3) invariant, 
and (4) “protest” responses, plus (5) refusals. These responses may represent simple 
mistakes or misunderstandings of the survey task, which introduce noise into results,
or they may be intentional responses to the parameters of the survey task that may 
confound respondents’ other values with the value of the health state being assessed. 
Unusable responses can be avoided through anticipation and careful design of survey 
instruments, particularly for speciﬁ c populations and health states, including cognitive
testing prior to ﬁ elding. Unusable responses can also be omitted from analyses or
analyzed separately. CONCLUSIONS: Unusable health utility survey responses chal-
lenge the validity of utility estimates and all analyses that incorporate these values, so
it is critical to minimize these responses. Mechanisms to correct errors are useful, but
may not address true preferences that are in response to elements of the measurement 
task and hence will not be corrected. Correction mechanisms may include tailoring
the task to particular situations when bias is anticipated, such as parent valuations of 
children’s states or individuals who express religious beliefs. Recognition of the preva-
lence of unusable data in health utility data sets and identifying methods for handling 
these errors is essential to understand the accuracy and precision of results and analy-
ses that depend thereon.
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Linguistic validation interviews are considered a vital step in the generally accepted
methodology for the translation of PRO measures. The translated PRO measure is 
administered to 5 or more native-speakers of the target language who also have a 
diagnosis of the condition of interest. OBJECTIVES: The objective of this study was 
to determine whether there is any evidence to suggest that the changes made are sig-
niﬁ cant enough to make the step worthwhile. METHODS: Examples of linguistic
validation changes were gathered from completed PRO translation projects. For one 
scale for which 26 translations were developed, changes made at the linguistic valida-
tion stage were examined quantitatively and qualitatively in order to determine the
number of changes made and the nature of these changes. The number of changes 
made per language as a result of the linguistic validation step ranged from 0 to 11,
with a mean of 1.4 changes. The changes made can be categorised as follows: Items 
where participants reported they did not understand. Items where participants
reported that they understood, but probing made it clear that confusion had arisen. 
Items where participants picked up on vocabulary that was not what they would
usually use, and items where participants spotted spelling and grammatical errors.
RESULTS: Whilst in purely numerical terms, the contribution of linguistic validation
to the translation process may seem small; in terms of the importance of those changes 
and in the conﬁ rmation of accuracy of the translated concept, its contribution is great. 
Whilst the translation may appear to be “correct” in other stages, only linguistic vali-
dation interviews show if the target population understands the translation as 
intended. CONCLUSIONS: The goal of translation of a PRO instrument is to achieve 
conceptual equivalence, and linguistic validation is arguably the most important step 
in assuring this.
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BACKGROUND: As electronic patient-reported outcome (ePRO) use expands, ques-
tions have arisen regarding the effect of presentation form and style on patient inter-
pretation and whether there is an optimal format to ensure clarity, ease of use, and
data quality. OBJECTIVES: To develop and validate a standardized ePRO interface
of common PRO question formats for use on desktop and tablet PCs to streamline
ePRO study implementation. METHODS: A web-based application was developed 
for desktop and tablet platforms with 52 demographic and clinical questions repre-
senting Likert-type, dichotomous, VAS and numeric rating scales. Adults from the 
general population were recruited through newspaper advertisements to participate in 
questionnaire completion and a cognitive debrieﬁ ng interview. Participants answered 
questions on either desktop or tablet PC and then reviewed the alternate format during 
the interview. Alternative question formats were reviewed to obtain further respondent 
insight and recommendations. RESULTS: Participants: N  47: mean age 54 years (23 
to 79), 51% female; 49% reported a chronic condition. 13% igh school education. 
Average completion time: desktop (n  22)  11 minutes; tablet PC (n  25)  13 
minutes, with all participants ﬁ nding their completion time acceptable. A total of 53% 
preferred desktop to tablet. Respondents found question formats easy to answer, 
except items requiring date and time entry (resolved through minor instruction revi-
sions) and the VAS. The VAS was presented three ways: anchors at 0 and 100, hash-
marks every ten digits, and hashmarks only with a display of the number selected.
77% preferred hashmarks; 83% liked the number displayed. No participants changed
their answer after the number appeared. CONCLUSIONS: Respondents provided
useful information on their perception and preferences for question format presented 
